drjnaidoo.bsky.social
Professor of Oncology at Beaumont RCSI Cancer Centre, Dublin | Thoracic Oncologist | Immunotherapy & Immune Toxicity | Adjunct faculty Johns Hopkins University
38 posts
2,226 followers
256 following
Prolific Poster
Conversation Starter
comment in response to
post
It’s a good question
comment in response to
post
Man I wish I was Sydney Poitier… and this is the closest I am going to get. Howdy!
comment in response to
post
Oncologic #ShakespeareSunday… now that’s upping the ante
comment in response to
post
Your lists probably say a lot about you… I have Science, Onc, LCSM, and Shakespeare 😀
comment in response to
post
Don’t forget the journals, prof societies & advocacy groups ! Some just kicking off @jtoonline.bsky.social @theaacr.bsky.social @iaslc.bsky.social @lungcancerresearch.bsky.social @egfrpositiveuk.bsky.social @younglungcancer.bsky.social
comment in response to
post
So true. The X-odus.
comment in response to
post
go.bsky.app/P1zYwRs
Please share with others in the Radiation Oncology/Cancer Research space in Ireland.
comment in response to
post
Do it Paolo 💪🏾
comment in response to
post
Hmm. And who were Dunning.. and who were Kruger?
comment in response to
post
Yes hard to see downsides here… updated versions will need to filter by location
comment in response to
post
In the opinion piece .. they explain that PCI was not mandatory in the ES SCLC trials exploring IO. Not in routine clinical practice.
comment in response to
post
Will start posting! Better say something controversial